explore -WSS

explore

author：explore 2025-08-26 23:48:43 - browse：6

Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid to be the first to develop a safer, simpler, and more scalable cure for sickle cell disease.

The French drugmaker will pay Scribe $40 million upfront and promise another $1.2 billion in potential milestones to license a DNA-cutting enzyme called CasX for use in a potential single-infusion treatment for the serious blood disorder — what’s known as in vivo therapy.CasX was discovered in CRISPR pioneer Jennifer Doudna’s lab, which subsequently spun out Scribe.

Scribe was planning to announce the news Tuesday, but it was published early Monday by GEN.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

WSS

WuXi out of biotech trade group, U.S. and China relations to blame

RaDonda Vaught links Vanderbilt hospital issues to patient death

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Wikipedia

explore

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

WuXi out of biotech trade group, U.S. and China relations to blame

ChatGPT in medicine: STAT answers readers' burning questions

How to save health care price transparency rules

In age of alternative facts, a scholarly course on calling out crap

UCLA team creates talking throat patch for voice disorders

Malaria cases in Florida and Texas: Here’s what you need to know

UCLA team creates talking throat patch for voice disorders

Dobbs anniversary: the lost opportunity of abortion as health care

UCLA team creates talking throat patch for voice disorders

leisure time

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

Male and female sex labels in research insufficient, scientists say

5 shark bites reported on Long Island as officials deploy surveillance drones

Readout Newsletter: Bristol, Sangamo, Gilead, and more

John Green on his newest strategy for fighting tuberculosis

EU moves toward latest gene techniques in food production to counter climate change, shortages

knowledge

Wikipedia

hotspot

explore